HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by MATTHEWS, C. M. Articles by RUTLEDGE, F. N. Search for Related Content PubMed PubMed Citation Articles by MATTHEWS, C. M. Articles by RUTLEDGE, F. N.

Pelvic Exenteration in the Elderly Patient

From the Department of Gynecology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

Abstract

Advanced age is frequently considered a contraindication to radical exenterative surgery. We reviewed the outcomes of 63 patients age 65 years or older who underwent pelvic exenteration between 1960-1991 at The University of Texas M. D. Anderson Cancer Center. Sixty-three percent had preexisting medical illnesses. Major or potentially lifethreatening complications were noted in 38% of the patients. An additional 38% experienced minor complications. Sixty percent experienced one or more infectious complications, including pyelonephritis, wound infection, sepsis, and flap necrosis. When both major and minor complications were considered, infectious morbidity was the single largest category. Although they are riot life-threatening, nonspecific infectious morbidity and transient confusion were the most frequent individual complications, occurring in 26 and 24% of patients, respectively. Twenty-four percent of the patients experienced no complications. Thirty-four percent of the postoperative survivors suffered late major morbidity. Operative mortality was 11%; multisystem failure was the most frequent cause of death. After a mean follow-up of 4 years, 22 patients were alive with no clinical evidence of disease. Twenty-one patients died of recurrent disease, with a median time to recurrence of 9.6 months. The 5-year survival rate for the group was 46%. In comparison, 363 patients younger than age 65 who underwent exenteration during the same period experienced an operative mortality rate of 8.5% and a 5-year survival rate of 45%, neither of which were significantly different from the rates found for the older group (P=.51 and .52, respectively). The morbidity and mortality of pelvic exenteration in our elderly patients are comparable to those noted in previous studies of younger patients, with similar 5-year survival rates. Therefore, age should not be considered a contraindication to exenteration.

This article has been cited by other articles:

				T. M. Pawlik, J. M. Skibber, and M. A. Rodriguez-Bigas Pelvic Exenteration for Advanced Pelvic Malignancies Ann. Surg. Oncol., May 1, 2006; 13(5): 612 - 623. [Full Text] [PDF]

				M. Friedlander and M. Grogan Guidelines for the Treatment of Recurrent and Metastatic Cervical Cancer Oncologist, August 1, 2002; 7(4): 342 - 347. [Abstract] [Full Text] [PDF]